Steven Galetta

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

Richard A. Rudick, William H. Stuart, Peter A. Calabresi et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis

Jerome P. Fisher, Dina Jacobs, Clyde Markowitz et al. · Ophthalmology · 2006 · 658 citations

Medicine, Neurology, Ophthalmology +16

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates

Beau M. Ances, Roberta Vitaliani, Robert A. Taylor et al. · Brain · 2005 · 484 citations · Full text

Medicine, Neurology, Neuroscience +15

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

Eva Havrdová, Steven Galetta, Michael Hutchinson et al. · The Lancet Neurology · 2009 · 473 citations

Life Sciences, Neurology, Pharmacotherapy +10

Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis

Lauren Talman, Esther R. Bisker, David J. Sackel et al. · Annals of Neurology · 2010 · 365 citations · Full text

Medicine, Neurology, Ophthalmology +17